May 21, 2025

New Biomarkers for Ultraprocessed Food Intake

NCI researchers identified blood and urine metabolite patterns that objectively measure ultraprocessed food consumption.

Conexiant

May 19, 2025

Growth Disrupted in One-Third of JIA Patients, Study

In a study of 107 children with juvenile idiopathic arthritis, researchers found that one-third had growth or pubertal disturbances—often linked to disrupted hormone levels and longer disease duration.

Conexiant

May 14, 2025

Semaglutide at Half Dose—Same Effect?

“When care is designed around the patient, lower doses often prove sufficient."

Reuters

May 14, 2025

Home Wash Leaves Scrubs Full of Superbugs

Home washing machines often fail to disinfect health care workers' uniforms, leaving antibiotic-resistant bacteria behind.

Conexiant

May 14, 2025

New Guidelines Trim Fat and Pages

Health Secretary Robert F. Kennedy, Jr. discusses upcoming 4-page dietary guidelines directing Americans to 'eat whole food' with major reforms, promising an early release before August.

Reuters

May 13, 2025

GLP-1s May Protect Against Obesity-Related Cancer

First-generation GLP-1 receptor agonists provide comparable protection against obesity-related cancers as bariatric surgery.

Conexiant

May 13, 2025

Tirzepatide Tops Semaglutide for Weight Loss

In the SURMOUNT-5 trial, tirzepatide led to a 20.2% mean weight loss in adults with obesity—significantly more than the 13.7% achieved with semaglutide.

Conexiant

May 05, 2025

True Heart Age Beyond Birthdays

New research uses cardiac MRI to calculate "functional heart age," showing obesity and other risk factors can age the heart by decades.

Conexiant

May 01, 2025

Semaglutide Shows Potential in Liver Disease Trial

Phase 3 trial finds weekly semaglutide 2.4mg significantly improved liver histology in patients with MASH and moderate to advanced fibrosis.

Conexiant